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Burden of Dyspepsia in Rural and Urban Asia
TO THE EDITOR: I have read with great interest the recently 
published article “Economic impact of dyspepsia in rural and ur-
ban Malaysia: a population-based study.”
1 This study tried to es-
timate the costs of dyspepsia in rural and urban population in 
Malaysia, a multi-ethnic Asian country with variable ethnic dis-
tribution between urban and rural population. The authors no-
ticed that the prevalence of dyspepsia and its associated economic 
impact are greater in an urban compared to a rural setting. The 
absolute cost to dyspepsia per 1,000 population per year was esti-
mated at USD14,816.10 and USD59,282.20 in the rural and ur-
ban populations respectively. Though the cost is far less than the 
cost of functional dyspepsia in Western countries, dyspepsia re-
mains considerable burden to the country.
2,3 The authors should 
be congratulated for completing this large-scaled epidemiology 
study, which contributes much to the scanty knowledge regard-
ing the economic impact of functional gastrointestinal disorder in 
Asia-Pacific region. Nevertheless, I would like to raise up 2 
concerns. 
First of all, it is not surprising that the economic impact for 
dyspepsia would be much higher in the urban than rural area, 
which might be resulted from the differences of the demographic 
characteristics and availability of medical resources between the 
rural and urban population. However, the true impact of (un-
investigated) dyspepsia could have been known if age-, sex- and 
co-mobidity matched non-dyspepsia subjects had been enrolled 
as the control group. With this approach, the extra-cost incurred 
from dyspepsia could have been obtained. And the differences in 
economic impact between the subjects with and without dyspep-
sia, no matter in urban or rural region, would have been more 
clear. The current study was a population study by investigating 
the gastrointestinal symptoms in over 2,000 residents in both the 
rural and urban Malaysia. Thus, the authors might be able to 
re-analyze the data to give us a better overview of the economic 
impact of dyspepsia in rural and urban Malaysia.
Secondary, for the dyspeptic patients in Malaysia, in both ru-
ral and urban region, antacid remained the mainstream of 
treatment. Very few patients in this series were given histamine 2 
(H2) blocker or proton pump inhibitor (PPI). Surprisingly, the 
price of H2 blocker in Malaysia is even lower than that of 
antacid. Current meta-analysis has already shown that the efficacy 
of antacid is no better than placebo, while both H2 blocker and 
PPI beat the placebo.
4 And PPI is suggested as the drug of 
choice for functional dyspepsia according to the current manage-
ment guidelines.
5,6 Then, people may raise a question: “why not 
give the dyspeptic patients with the more effective and cheaper 
drug like H2 blocker, instead of the antacid?” Furthermore, the 
satisfactory response under the treatment of antacid and the role 
of Helicobacter pylori of in these dyspeptic patients may be the un-
ressolved, but important, issues in the current paper. 
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